Diabetes
Metronom sees its "disruptive" technology pushing the advancement of digital diabetes management, providing patients with diabetes-related education, data analysis and other services.
The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes on multiple-dose injection therapy.
Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the software platforms and/or medical devices offered by the diabetes management companies.
Dubai’s GluCare has released its first set of findings, taken over 90 days since launch. Report shows that diabetic patients achieved an average HbA1c reduction of 1.7% in just three months.
The semiconductor player claims success with D-SaLife in a recent clinical trial involving diabetic outpatients.
The Palo Alto startup said that 2020 was its strongest year to date.
DarioHealth buys into MSK with Upright Technologies acquisition and announces $70M private placement
The $31 million purchase will add new capabilities to DarioHealth's condition management and behavior change platform.
Outcomes from the randomized controlled trial were presented today at a virtual conference. The company and its research partners say this study differs from others due to its size and length.
Following a soft launch in September, the GluCare Integrated Diabetes Center says it monitors the data of its patients in real-time, plus employs digital therapeutics.
The aim is to use the technology to track daily patient data and “plan interventional strategies in real-time to avoid complications of the disease,” the centre said.